CIC (circulating immune complex) antibody buffer solution dissociation agent for immune complex buffer dissociation agent

A technology of immune complexes and dissociation agents, applied in the field of medical testing, to achieve good repeatability and improve work efficiency

Inactive Publication Date: 2014-05-07
THE PLA 117 HOSPITAL
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] Aiming at the technical problems that the existing CIC detection technology and detection process cannot simultaneously have specificity, sensitivity, batch efficiency, good repeatability, and no interference, the present invention discloses an immune complex buffer dissociation solution that solves the above technical problems Agent, also discloses the application field of this kind of immune complex buffer dissociation agent

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • CIC (circulating immune complex) antibody buffer solution dissociation agent for immune complex buffer dissociation agent
  • CIC (circulating immune complex) antibody buffer solution dissociation agent for immune complex buffer dissociation agent
  • CIC (circulating immune complex) antibody buffer solution dissociation agent for immune complex buffer dissociation agent

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0042] An immune complex buffer dissociation agent, based on the following volume ratio, each component and content are: 135 μl of CIC separation agent, 290 μl of CIC detergent, 5 μl of CIC reconstitution solvent, 65 μl of CIC antibody buffer solution Dissociating agent and 65 μl of CIC antibody buffer to dissociate neutralizing agent.

[0043] Wherein, every 1 L of CIC separation agent includes the following components: 5.2 g of borax, 4.1 g of boric acid, 70 g of polyethylene glycol, 6.2 g of sodium chloride, 100 μl of liquid biological preservative, and distilled water as the balance.

[0044] Each 1 L of CIC detergent includes the following components: 5.2 g of borax, 4.1 g of boric acid, 35 g of polyethylene glycol, 8.0 g of sodium chloride, 100 μl of liquid biological preservative, and distilled water as the balance.

[0045] Each 1 L of CIC reconstitution solvent includes the following components: 8.0 g of sodium chloride, 0.01 g of sodium hydroxide, 50 μl of polyethyle...

Embodiment 2

[0057] An immune complex buffer dissociation agent, based on the following volume ratio, each component and content are: 165 μl of CIC separation agent, 315 μl of CIC detergent, 16 μl of CIC reconstitution solvent, 76 μl of CIC antibody buffer solution Dissociating agent and 76 μl of CIC antibody buffer to dissociate neutralizing agent.

[0058] Wherein, every 1L of CIC separation agent includes the following components: 7.7g of borax, 6.1g of boric acid, 90g of polyethylene glycol, 9.2g of sodium chloride, 500μl of liquid biological preservative, and the balance is distilled water.

[0059] Each 1L of CIC detergent includes the following components: 7.7g of borax, 6.1g of boric acid, 45g of polyethylene glycol, 11.7g of sodium chloride, 500μl of liquid biological preservative, and the balance is distilled water.

[0060] Each 1 L of CIC reconstitution solvent includes the following components: 9.5 g of sodium chloride, 0.03 g of sodium hydroxide, 500 μl of polyethylene glycol...

Embodiment 3

[0072] An immune complex buffer dissociation agent, based on the following volume ratio, each component and content are: 150 μl of CIC separation agent, 300 μl of CIC detergent, 10 μl of CIC reconstitution solvent, 70 μl of CIC antibody buffer solution Dissociating agent and 70 μl of CIC antibody buffer to dissociate neutralizing agent.

[0073] Wherein, every 1L of CIC separation agent includes the following components: 6.4g of borax, 5.1g of boric acid, 80g of polyethylene glycol, 7.7g of sodium chloride, 200μl of liquid biological preservative, and the balance is distilled water.

[0074] Each 1L of CIC detergent includes the following components: 6.4g of borax, 5.1g of boric acid, 40g of polyethylene glycol, 9.9g of sodium chloride, 200μl of liquid biological preservative, and the balance is distilled water.

[0075] Each 1 L of CIC reconstitution solvent includes the following components: 9.0 g of sodium chloride, 0.016 g of sodium hydroxide, 300 μl of polyethylene glycol...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
quality scoreaaaaaaaaaa
Login to view more

Abstract

The invention relates to the field of medical detection, and discloses a CIC (circulating immune complex) antibody buffer solution dissociation agent for an immune complex buffer dissociation agent. Every 1L of the CIC antibody buffer solution dissociation agent comprises glycine, 35-37% concentrated hydrochloric acid, sodium chloride, liquid biological preservative and distilled water. The method for detecting CIC by using the immune complex buffer dissociation agent establishes a standard operation process for specifically detecting the antibody in the CIC, which is the problem that can not be solved by the existing CIC detection methods at present. The immune complex buffer dissociation agent has the technical characteristics of high specificity and sensitivity, high efficiency and favorable repetitiveness, is free from interference, and can perform quantitative or qualitative detection. The immune complex buffer dissociation agent is used for detecting CIC in body fluid samples of patients with infectious diseases, incretion metabolic diseases, autoimmune diseases and part of neoplastic diseases.

Description

technical field [0001] The invention relates to the field of medical detection, in particular to a CIC antibody buffer dissociation agent used for immune complex buffer dissociation agents. Background technique [0002] After bacteria, viruses and other pathogens invade the body or allergens (antigens, including self-antigens) stimulate the body to generate an immune response, and then produce specific immune effector cells or antibodies, and specifically bind to the antigen, the resulting complex is called Immune complexes (also known as antigen-antibody complexes, immune complexes, IC) mainly include IgG, IgM, IgA, and IgE type immune complexes, among which IgG and IgM are the most common. Due to the different ratios of antigen and antibody, the formed IC molecules have different sizes, usually in three forms: First, when the ratio of antigen to antibody is appropriate, large insoluble ICs (greater than 19S) are formed, which are easily captured, phagocytized and cleared b...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): G01N33/53
CPCG01N33/54393G01N33/564G01N2800/50G01N2800/52
Inventor 成军张益明马炬明陈达伟孙长贵戴玉柱王国政江晓肖
Owner THE PLA 117 HOSPITAL
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap